IFNA1 and influenza: Our findings suggest that IFN-β treatment, especially late IFN, to healthy NS people infected with flu would only exaggerate the IFN levels in the host and exogenous IFNs promote pro-inflammatory responses and recruit extra granulocytes and monocytes to the lung, which would contribute to worse disease outcomes.